HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Edward J Cupler Selected Research

alpha-Glucosidases (Acid Maltase)

10/2015Diagnosis and treatment of late-onset Pompe disease in the Middle East and North Africa region: consensus recommendations from an expert group.
3/2012Consensus treatment recommendations for late-onset Pompe disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Edward J Cupler Research Topics

Disease

2COVID-19
01/2022 - 06/2021
2Glycogen Storage Disease Type II (Pompe's Disease)
10/2015 - 03/2012
1Multiple Sclerosis
01/2022
1Infections
06/2021
1Myasthenia Gravis
12/2010
1Acute Kidney Injury (Acute Renal Failure)
06/2010
1Nephrogenic Fibrosing Dermopathy
06/2010
1Renal Insufficiency (Renal Failure)
06/2010
1Macrophagic myofasciitis
06/2008
1Myositis (Idiopathic Inflammatory Myopathies)
06/2008
1Granuloma
06/2008

Drug/Important Bio-Agent (IBA)

2teriflunomideIBA
01/2022 - 06/2021
2alpha-Glucosidases (Acid Maltase)IBA
10/2015 - 03/2012
2EnzymesIBA
10/2015 - 03/2012
2GlycogenIBA
10/2015 - 03/2012
1Pharmaceutical PreparationsIBA
01/2022
1siponimodIBA
06/2021
1Natalizumab (Tysabri)FDA Link
06/2021
1Alemtuzumab (Campath)FDA Link
06/2021
1TabletsIBA
06/2021
1ocrelizumabIBA
06/2021
1Interferon-betaIBA
06/2021
1CladribineFDA LinkGeneric
06/2021
1Fingolimod Hydrochloride (FTY720)FDA Link
06/2021
1Dimethyl FumarateIBA
06/2021
1AcidsIBA
03/2012
1AntibodiesIBA
12/2010
1Cholinergic ReceptorsIBA
12/2010
1Rituximab (Mabthera)FDA Link
12/2010
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2010
1GadoliniumIBA
06/2010
1Periodic AcidIBA
06/2008
1VaccinesIBA
06/2008
1Aluminum Hydroxide (Algeldrate)FDA Link
06/2008

Therapy/Procedure

2Therapeutics
06/2021 - 12/2010
1Enzyme Replacement Therapy
03/2012